Symphogen
DenmarkEntry
2019
Hold
1yr
Exit
2020
Who owns Symphogen?
Symphogen was owned by Sunstone Life Science Ventures through Sunstone Life Science Ventures IV (2015 vintage) from 2019 to 2020, exited via Trade Sale.
Buyer identity available on Pro.
Hand-verified · updated 2026-08-18
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2020
More from Sunstone Life Science Ventures IV
Other portfolio companies in the same fund.
Sweden
Switzerland
Finland
More PE-backed in Biotech
Comparable biotech deals from other GPs.
US
UKTrack Symphogen
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Symphogen?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Symphogen.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue